Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism-Reference-Cited by-同舟云学术

Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism

Published:2019-08 Issue:2 Volume:30 Page:385-401.e9
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Collin de l’Hortet Alexandra,Takeishi Kazuki,Guzman-Lepe Jorge,Morita Kazutoyo,Achreja Abhinav,Popovic Branimir,Wang Yang,Handa Kan,Mittal Anjali,Meurs Noah,Zhu Ziwen,Weinberg Frank,Salomon Michael,Fox Ira J.,Deng Chu-Xia,Nagrath Deepak,Soto-Gutierrez Alejandro

Funder

NIH), United States

American Liver Foundation, United States

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference73 articles.

1. A protein-truncating HSD17B13 variant and protection from chronic liver disease;Abul-Husn;N. Engl. J. Med.,2018

2. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism;Achreja;Metab. Eng.,2017

3. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity;Anjani;J. Hepatol.,2015

4. The genetics of NAFLD;Anstee;Nat. Rev. Gastroenterol. Hepatol.,2013

5. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha);Aoyama;J. Biol. Chem.,1998

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy;Frontiers in Cell and Developmental Biology;2024-09-11

2. Organoid-guided precision hepatology for metabolic liver disease;Journal of Hepatology;2024-05

3. SIRT1: Harnessing multiple pathways to hinder NAFLD;Pharmacological Research;2024-05

4. Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy;2024-04-26

5. Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays;2024-03-29